Spectral AI (MDAI) Competitors

Monogram Orthopaedics (NASDAQ:MGRM) and Spectral AI (NASDAQ:MDAI) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, risk, analyst recommendations, profitability, media sentiment, dividends, earnings, valuation and community ranking.

Do insiders & institutionals believe in MGRM or MDAI?

0.4% of Monogram Orthopaedics shares are owned by institutional investors. Comparatively, 67.1% of Spectral AI shares are owned by institutional investors. 28.1% of Monogram Orthopaedics shares are owned by company insiders. Comparatively, 56.7% of Spectral AI shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Does the MarketBeat Community favor MGRM or MDAI?

Spectral AI received 4 more outperform votes than Monogram Orthopaedics when rated by MarketBeat users. Likewise, 100.00% of users gave Spectral AI an outperform vote while only 75.00% of users gave Monogram Orthopaedics an outperform vote.

Company	Underperform	Outperform
Monogram Orthopaedics	Outperform Votes 3 75.00%	Underperform Votes 1 25.00%
Spectral AI	Outperform Votes 7 100.00%	Underperform Votes No Votes

Which has more volatility and risk, MGRM or MDAI?

Monogram Orthopaedics has a beta of 1.66, suggesting that its stock price is 66% more volatile than the S&P 500. Comparatively, Spectral AI has a beta of 0.62, suggesting that its stock price is 38% less volatile than the S&P 500.

Which has stronger valuation and earnings, MGRM or MDAI?

Monogram Orthopaedics has higher earnings, but lower revenue than Spectral AI. Monogram Orthopaedics is trading at a lower price-to-earnings ratio than Spectral AI, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Monogram Orthopaedics	$365.00K	239.29	-$13.74M	-$0.46	-5.38
Spectral AI	$27.26M	1.01	-$20.85M	-$0.84	-1.42

Does the media favor MGRM or MDAI?

In the previous week, Spectral AI had 11 more articles in the media than Monogram Orthopaedics. MarketBeat recorded 11 mentions for Spectral AI and 0 mentions for Monogram Orthopaedics. Spectral AI's average media sentiment score of 0.36 beat Monogram Orthopaedics' score of 0.00 indicating that Spectral AI is being referred to more favorably in the news media.

Company	Overall Sentiment
Monogram Orthopaedics	Neutral
Spectral AI	Neutral

Is MGRM or MDAI more profitable?

Monogram Orthopaedics has a net margin of 0.00% compared to Spectral AI's net margin of -40.78%. Spectral AI's return on equity of 0.00% beat Monogram Orthopaedics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Monogram Orthopaedics	N/A	-130.90%	-106.38%
Spectral AI	-40.78%	N/A	-77.87%

Do analysts rate MGRM or MDAI?

Monogram Orthopaedics currently has a consensus price target of $5.40, indicating a potential upside of 118.18%. Spectral AI has a consensus price target of $4.75, indicating a potential upside of 299.50%. Given Spectral AI's higher possible upside, analysts clearly believe Spectral AI is more favorable than Monogram Orthopaedics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Monogram Orthopaedics	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	3.50
Spectral AI	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	3.33

Summary

Spectral AI beats Monogram Orthopaedics on 12 of the 18 factors compared between the two stocks.